Skip to content

Assessment of Novel Technology to Facilitate Drainage in Ostomy Pouches: OUTFLOW Study

Assessment of Novel Technology to Facilitate Drainage in Ostomy Pouches: OUTFLOW Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06394115
Acronym
OUTFLOW
Enrollment
40
Registered
2024-05-01
Start date
2022-08-01
Completion date
2023-06-19
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colostomy Stoma, Ileostomy - Stoma

Keywords

Ileostomy, Colostomy, Quality of Life

Brief summary

The overall aim of this study is to determine the performance and safety of a novel coated material inside Convatec Ostomy Pouches, and to explore the clinical and quality of life benefits that may occur with the use of the test product. A minimum of 30 subjects, and a maximum of 40 subjects will be recruited to obtain 30 complete datasets comprised of a minimum of 15 colostomy and minimum of 10 ileostomies.

Interventions

DEVICEOstomy pouch

Ostomy pouch coated with novel technology

Sponsors

ConvaTec Inc.
Lead SponsorINDUSTRY
Princeton Consumer Research
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* • Subjects with a colostomy or ileostomy * Age 18 years and over * Medically stable in the opinion of the investigator * Are able and willing to provide informed consent * Are able and willing to attend study visits * Currently use the same models of pouches as required by the study * Have a recent history of frequent pancaking (colostomy patients only) * Willing to stop using any lubricants in the pouches whilst participating in the study. * Subject has a valid email address for the Investigator to send links to study questionnaires and has access to a web enabled device.

Exclusion criteria

* • Subjects with any peristomal skin condition classified as non-intact skin at the time of enrolment * Subjects who maybe receiving any concomitant treatment and/or medications which could impact the consistency of effluent during the study period. * Allergic to any components of the Novel Lubricant inclusive of Soyabean and/or Vitamin E.

Design outcomes

Primary

MeasureTime frameDescription
Performance of Convatec ostomy pouches which have the novel coating16 daysTo demonstrate the performance of Convatec ostomy pouches which have the novel coating

Secondary

MeasureTime frameDescription
to investigate the safety of Convatec Ostomy Pouches modified with a novel coating16 daysEvaluation of device related safety events during the treatment period and Evaluation of quality of life and patient perception of product.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026